Tenn. Comp. R. & Regs. 0940-05-36-.05
Medication Storage
Effective Jun 27, 2019Authority: T.C.A. §§ 4-3-1601, 4-4-103, 4-5-202, 4-5-204, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2- 302, 33-2-402, 33-2-403, 33-2-404, 33-2-407, and Chapter 978 of the Public Acts of 2018.Tennessee Department of Mental Health and Substance Abuse Services
- (1) Buprenorphine products shall be stored in a secure storage area in compliance with 21 C.F.R. Part 1301.72.
- (2) All prescription drugs and controlled substances, and related materials, shall be stored in an area not accessible to the public.
- (3) The patient waiting area shall be physically separated from the buprenorphine storage and dispensing area.
Authority: T.C.A. §§ 4-3-1601, 4-4-103, 4-5-202, 4-5-204, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2- 302, 33-2-402, 33-2-403, 33-2-404, 33-2-407, and Chapter 978 of the Public Acts of 2018. Administrative History: Original rule filed August 29, 2003; effective December 29, 2003. Repeal filed July 21, 2004; effective November 26, 2004. New rules filed March 29, 2019; effective June 27, 2019.